摘要
目的:探讨不同期别的鼻咽癌(nasopharyngeal carcinoma,NPC)患者血清中CD62p、IL-6、IL-8的表达与肿瘤分期及预后的关系。方法:采用酶联免疫吸附法(ELISA)检测83例病理确诊为NPC的各期放疗前患者血清与17例正常人血清中CD62p、IL-6、IL-8的表达,分析各指标的表达与肿瘤分期及预后的关系。结果:CD62p、IL-6、IL-8 3个指标在NPC患者血清中的表达明显高于正常人群(P<0.01);与患者的年龄和性别无关(P>0.05);与肿瘤的TNM分期及肿瘤临床分期呈正相关(P<0.05);且CD62p、IL-6、IL-8 3个指标间存在正相关性(P<0.05)。结论:CD62p、IL-6、IL-8 3个指标在各期鼻咽癌患者血清中高表达与鼻咽癌的TNM分期及肿瘤临床分期呈正相关,可以作为NPC肿瘤转移的前瞻性指标。
Objective:To analyse the expression of CD62p(P - selectin) ,IL -6 (interleukin -6) ,IL - 8(interleukin- 8) in different clinical stages of NPC serum; and the relation with stages. Methods: Eighty three serum specimens of pathologically comfirmed different clinical stages NPC were tested, 17 health specimens as comparison group. The expression of CD62p, IL - 6, IL - 8 in were examined by enzyme - linked immunosorbent assay (ELISA). Results: The expressions of CD62p,IL - 6, IL - 8 in NPC serum were higher than the health ( P 〈 0.01 ) ; not related to the age and sex ( P 〉 0.05 ), but correlated with the TNM stages ( P 〈 0.05 ) ; The positive correlation existed in CD62p, IL - 6, IL - 8 ( P 〈 0.05 ). Conclusion: The expressions of CD62p, IL - 6, IL - 8 in NPC serum have relationship with the TNM stages and clinicaal stages, can be used as prognostic molecular markers in NPC patients.
出处
《现代肿瘤医学》
CAS
2009年第2期231-234,共4页
Journal of Modern Oncology
基金
广西科学基金项目(回国基金)(编号:厅59号)